Structural determinants of catecholamine action on in vitro insulin release.
D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D006224:Cricetinae; D000242:Cyclic AMP / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007545:Isoproterenol / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010627:Phenethylamines / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014439:Tyramine / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology
D002087:Butyrates; D002395:Catecholamines; D007328:Insulin; D010627:Phenethylamines; D010648:Phenylacetates; D010656:Phenylephrine; D014443:Tyrosine; D010649:Phenylalanine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D000242:Cyclic AMP; D005947:Glucose; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine